Cancer is one of the humanity’s most stubborn diseases. For doctors to be able to treat cancer more efficiently, they need data to do their work. Genome sequence data as well therapeutic data is very crucial in the war against cancer. Eric Lefkofsky, a seasoned entrepreneur in the field of technology specifically big data and analytics is keen on setting up a database that will aggregate this data and avail it to oncologists. His startup, Tempus has already made strides in the field by launching a program that will see it gather therapeutic and genomic data from 1,000 breast cancer patients.
Speaking at a recent Fortune Brainstorm Health Conference that was held in San Diego, Eric Lefkofsky revealed there is a lot of patient data in the public domain but what is missing is sources which can combine data from a patient’s genome sequence and that of their response to various therapies.
Therapeutic data on the response of different patients to different treatments is as equally important as data on the genome structure. Medical professionals need to know why multiple patients respond differently to the same therapy. Could it be because they are already dealing with other medical conditions? Or is it because of the DNA or RNA makeup in their genes? Such question can only be answered by big data that is analyzed to provide patterns that could give useful insights.
According to Eric Lefkofsky, for a group of breast cancer patients who are under the Herceptin therapy, a researcher needs to establish why the treatment has varying success rates in different patients. If one needed genome sequence and therapeutic data of a patient, they would require a grant and a window period of not less than 90 days before they can lay their hands on this precious data.These data bottlenecks make the work of oncologists very hard. Eric Lefkofsky is keen on bridging this information and data gap.
Over the years, Eric lefkofsky has come up with some of the best innovations that have enabled him to create a fortune for himself. According to Forbes, Eric is a billionaire who made most of his fortune from his first venture Groupon. Together with his trusted business partner, Brad Keywell, Eric grew Groupon to an online retail giant and what Eric knows.
More visit: https://twitter.com/lefkofsky